Pharmacokinetics, Safety, and Tolerability Study of GOPRELTO® Nasal Solution and NUMBRINO™ Nasal Solution
Pharmacokinetics, Safety, and Tolerability Study of GOPRELTO® Nasal Solution and NUMBRINO™ Nasal Solution
Recruiting · NCT04792034 · Registry updated 2025-12-26Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Pharmacokinetics, Safety, and Tolerability Study of GOPRELTO® Nasal Solution and NUMBRINO™ Nasal Solution | Fistula, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms | Recruiting | Phase 3 | 2025-12-26 | NCT04792034 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| LXO Group | 1 |
| Omnivium Pharmaceuticals LLC | 1 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| SCENT Sleep and Allergy, 110 Highland Center Drive | Columbia | United States | 1 |
| SCENT Sleep and Allergy, 145 Park Central | Columbia | United States | 1 |
| SCENT Sleep and Allergy, 15 Exchange Dr. | Lugoff | United States | 1 |
| South Carolina ENT, Sleep and Allergy | Columbia | United States | 1 |